Cardiol Therapeutics Inc. - COM CL A (CRDL)

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Equity / COM CL A
Number of holders
1
Total Shares
287K
Shares change
+43.6K
Total reported value, excl. options
$876K
Value change
+$133K
Put/Call ratio
0
Number of buys
1
Number of sells
0
Price
$3.05
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.